What can GHK-Cu tell us about skin?
GHK-Cu is a tiny chain of protein building blocks bound to copper. In skincare, it's often called copper tripeptide-1. The cream research gives us something to talk about, though rather less than the biggest claims suggest.
What the cream studies say
A review of GHK-Cu skin research describes small cream studies in women around 50, reporting less looseness, fewer fine lines and better skin appearance. Those are relevant findings if you're curious about firmness. They're also reports we're reading through a review.
Some original accounts were a conference presentation, a university report and a book chapter. That leaves less detail to check than a full trial paper. We can say the review reports improvements. We can't treat that as a firm prediction about what someone will see in the mirror.
Liking it and measuring it are different
A small trial after laser skin treatment makes that difference clear. People using copper-peptide skincare reported greater satisfaction. But objective assessments found no significant improvement in wrinkles or overall skin quality.
Both results belong in the story. Satisfaction matters to a person; a measured change answers another question. This was freshly laser-treated skin, so the result doesn't settle what every cream does on everyday skin. It does make “people liked it” a less useful shortcut for “it changed their skin”.
Getting through skin matters
An ingredient has to reach the place where it's meant to act. A review of topical delivery describes two problems for GHK-Cu: getting through skin and keeping the ingredient from breaking down. It also highlights the shortage of clinical studies.
That's why a familiar name on a label tells only part of the story. The finished cream matters, too. A finding about one cream doesn't establish the same result from another. For a reader, “which cream was tested?” is a more useful question than “is copper good for skin?”
Creams don't answer injection questions
Community reports mention redness, itching and dryness with topical copper products. These are anecdotes, not reliable counts of side effects. Small human studies leave uncommon and longer-term problems hard to judge.
For injections, the FDA describes possible immune reactions related to peptide clumping or impurities, with limited human safety data. There is no FDA-approved GHK-Cu medicine. A prescription doesn't change that, and a cosmetic history doesn't establish injection safety. The GLOW comparison takes up the next question: what changes when more peptides join the mixture?